Table 2.
Prescription patterns for the five medicines for secondary prevention (N = 2471)
| Drug type | Prescriptions n (%) | Range (% in lowest – highest scoring hospital) | Guideline adherencea
n (%) |
Range (% in lowest – highest scoring hospital) |
|---|---|---|---|---|
| Acetylsalicylic acid | 2271 (91.9 %) | 86.6–97.2 % | 2460 (99.6 %) | 98.6–100 % |
| P2Y12 receptor inhibitor | 2189 (88.6 %) | 70.3–95.9 % | 2293 (92.8 %) | 75.7–98.6 % |
| Statin | 2294 (92.8 %) | 81.1–97.4 % | 2363 (95.6 %) | 83.8–98.9 % |
| Beta-blocker | 2220 (89.8 %) | 83.5–99.0 % | 2360 (95.5 %) | 90.5–99.0 % |
| ACE inhibitor | 1603 (64.9 %) | 47.5–74.5 % | 1898 (76.8 %) | 57.9–93.1 % |
| All 5 medicines | 1214 (49.1 %) | 28.2–59.0 % | 1708 (69.1 %) | 42.1–87.0 % |
| 4 out of 5 medicines | 2068 (83.7 %) | 67.8–91.0 % | 2297 (93.0 %) | 78.4–99.0 % |
ACE angiotensin-converting enzyme, STEMI ST-segment elevation myocardial infarction, NSTEMI non-ST-segment elevation myocardial infarction, UA unstable angina pectoris
aGuideline adherence refers to either prescription of the medicine or documentation of a contraindication